Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives

Author:

Soleimani Anvar1,Bahreyni Amirhossein2,Roshan Mostafa K.1,Soltani Arash1,Ryzhikov Mikhail3,Shafiee Mojtaba4,Soukhtanloo Mohammad1,Jaafari Mahmoud R.56,Mashkani Baratali1,Hassanian Seyed M.178ORCID

Affiliation:

1. Department of Clinical Biochemistry Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

2. Department of Clinical Biochemistry and Immunogenetic Research Center Faculty of Medicine, Mazandaran University of Medical Sciences Sari Mazandaran Iran

3. Division of Pulmonary and Critical Care Medicine Washington University, School of Medicine Saint Louis Missouri

4. Department of Nutrition Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran

5. Nanotechnology Research Center, Mashhad University of Medical Sciences Mashhad Iran

6. Department of Pharmaceutical Nanotechnology School of Pharmacy, Mashhad University of Medical Sciences Mashhad Iran

7. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences Mashhad Iran

8. Microanatomy Research Center, Mashhad University of Medical Sciences Mashhad Iran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3